Company Overview

Development Stage

About the Company

Gemian Biotechnology (Shanghai) Co., Ltd., established in February 2011, is a high-tech enterprise integrating research, development, and sales of biological products and biological research products, specializing in cutting-edge biotechnology research and development. Adhering to the corporate philosophy of "Focus, Innovation, Integrity, and Harmony," the company is committed to providing biological technology services and related products, offering technical services and products such as virus packaging, stable cell line construction, vector construction, protein expression, gene function, and drug screening to numerous pharmaceutical companies and research institutions both domestically and internationally. The core team members have extensive R&D experience at renowned academic institutions and world-class pharmaceutical companies. Gemian has established first-class laboratories in Shanghai·Kangqiao·Xingchuang Park, featuring platforms for virus packaging and purification, molecular biology, cell biology, protein expression, and drug screening. To facilitate gene transfection research, Gemian has developed a new generation of nanomaterial-based transfection reagents suitable for efficient transfection of various cell types, particularly for virus packaging. With years of accumulation, the company can provide customers with thousands of off-the-shelf viruses, ensuring research speed and quality. Virus packaging services include lentivirus, adenovirus, adeno-associated virus, and baculovirus. Vector construction covers overexpression vectors, shRNA expression vectors, miRNA expression vectors, lncRNA, point mutation, gene retrieval, gene synthesis, etc. Cell function assays include cell proliferation, colony formation, cell cycle, apoptosis, migration, invasion, wound healing, Western Blot, co-immunoprecipitation, etc. Protein expression and purification cover prokaryotic proteins, eukaryotic proteins, insect baculovirus proteins, etc. Special topic research includes miRNA and target gene studies, lncRNA research, overall tumor research, cell immortalization, cell pathway reporter genes, iPSC induction-related research, autophagy research, cell tracing and localization research, etc. Products include AAV optogenetic products, over 100 reporter gene series in stock, ORF clones, miRNA clones, shRNA clones and shRNA libraries in stock, the most complete iPSC induction gene products, mycoplasma detection and elimination reagents, Cre, SV40T lentivirus and adenovirus, luciferase in vivo imaging viruses and reagents. Currently, Gemian continues to develop high-tech and products to meet the evolving needs of biological research. We welcome feedback and suggestions from customers to better serve users. Our high-quality products and services will make your research faster and more convenient. Welcome to join our team.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Gemian Biotechnology How Fast Is Hiring Growing? (19 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 57%
  • 2024: Down 3%
  • 2023: Up 244%
  • 2022: Down 84%
Gemian Biotechnology Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Gemian Biotechnology Campus Recruitment & Advanced Degree Talent Demand
Master's 7
Note: How fast is hiring at Gemian Biotechnology (Shanghai) Co., Ltd. growing? Gemian Biotechnology2026: 30 openings (down 36%), 2025: 47 openings (up 57%), 2024: 30 openings (down 3%), 2023: 31 openings (up 244%), 2022: 9 openings (down 84%), 2021: 57 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Gemian Biotechnology Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 40%
  • 2024: Flat 0%-
Gemian Biotechnology Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Gemian Biotechnology (Shanghai) Co., Ltd. growing? Gemian BiotechnologyMaster's recruitment over the years: 2025: 7 openings (up 40%), 2024: 5 openings (flat), 2023: 5 openings.

Gemian Biotechnology R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Gemian Biotechnology (Shanghai) Co., Ltd.? Based on an analysis of Gemian Biotechnology's job postings over the past year, "生物/制药/化工/环保类" demand: 37%, "其他(研发和技术类)": 10.9%, "科研类": 6.5%, "农林渔类": 4.3%, "计算机/网络/技术类": 2.2%. For reference only.

Gemian Biotechnology — What Are the Salaries Like? (46 records)

Manage
Gemian Biotechnology Salary Overview
salary range: 4.5K - 50K, 54.3% of roles pay ¥15-30K
Note: salary statistics are based on 46 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Gemian Biotechnology (Shanghai) Co., Ltd.?Gemian Biotechnology54.3% of positions earn 15-30K, Undergraduate salary: ¥。销售类 average salary ¥19.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Gemian Biotechnology

(More)
Are salaries high at Gemian Biotechnology (Shanghai) Co., Ltd.? We provide: 销售,业务专员,国际业务,实验员,技术支持,大客户,sa,市场,法语,产品专员,俄语,发货,司机,后勤助理,收发,日语,研发主管,研发工程师,组长,西班牙语. Click to view detailed salary analysis by job.

Gemian Biotechnology honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Gemian Biotechnology Related Industry Tags

Job Category

  • 销售类
    50% of total 50%
  • 生物/制药/化工/环保类
    37% of total 37%
  • 翻译类
    13% of total 13%
  • 其他(研发和技术类)
    10.9% of total 10.9%

Education

  • 本科
    60.9% of total 60.9%
  • 硕士
    21.7% of total 21.7%
  • 大专
    10.9% of total 10.9%
  • 高中
    4.3% of total 4.3%

Experience

  • 1-3年
    47.8% of total 47.8%
  • 3-5年
    34.8% of total 34.8%
  • 不限
    15.2% of total 15.2%
  • 5-10年
    2.2% of total 2.2%
View Detailed Analysis

What does Gemian Biotechnology (Shanghai) Co., Ltd. require? Who is Gemian Biotechnology hiring? Gemian Biotechnology recruitment: 销售类占比最多占50%,其次是生物/制药/化工/环保类占37%. What education can get in at Gemian Biotechnology? 本科占比最多占60.9%,其次是硕士占21.7%. High education required at Gemian Biotechnology? 硕士占21.7%. Work experience required at Gemian Biotechnology? 1-3年占比最多占47.8%,其次是3-5年占34.8%. Where are the job locations at Gemian Biotechnology? 上海占比最多占91.3%,其次是北京占8.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 150万(元)
Legal Representative: 孙瑶
Date Established:
Credit Code: 913101155852492064
Registered Address: 上海市浦东新区康威路299号1幢5层505、506、507室

Partners & Suppliers

吉满生物科技为药明康德提供基因载体构建和细胞系开发服务。 Source
合作客户 合同研发服务
吉满生物科技从西格玛购买生化试剂和抗体。 Source
供应商 生物试剂供应商
吉满生物科技从赛默飞采购细胞培养试剂和实验耗材。 Source
供应商 生物试剂供应商
吉满生物科技与复旦大学生命科学学院合作进行基因编辑技术开发。 Source
供应商 高校/研究院合作
吉满生物科技与上海交通大学建立联合实验室,共同开展细胞生物学研究。 Source
供应商 高校/研究院合作

People who follow Gemian Biotechnology also follow

Gemian Biotechnology Competitors (Similar Companies)

“A large global manufacturer of custom DNA synthesis products”
生命科学 分子酶 研发 生产
知识产权代理 律师事务所/法律服务 商标申请 商标事务所
新材料 聚乙烯/PE 化工/化学 塑料合金
精密机械零部件 机械零部件 生产 机械五金加工
服装/服饰 纺织 丝绸 化纤面料
工程设计 建筑幕墙 机电设备安装 门窗
品牌策划 艺术涂料 墙面装饰产品 代理分销
离心泵 多级离心泵 自动化 生产
安全设备 呼吸防护设备 生产 安全防护
开关电源 变电站 直流/DC电源 电力
造纸/造纸厂/纸业 打印纸 文化用纸 双面胶
模具 模具设计 模具开发 硅胶
塑胶零件 塑胶零配件 眼镜 配件
电机 压缩机 制冷 制冷设备

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates